Marinus Pharmaceuticals (MRNS)
(Delayed Data from NSDQ)
$1.44 USD
0.00 (0.00%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $1.45 +0.01 (0.69%) 7:34 PM ET
3-Hold of 5 3
F Value C Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/9/24 |
---|---|
Current Quarter | -0.68 |
EPS Last Quarter | -0.74 |
Last EPS Surprise | -15.63% |
ABR | 1.55 |
Earnings ESP
|
0.74% |
---|---|
Current Year | -2.23 |
Next Year | -1.14 |
EPS (TTM) | -2.63 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 8.69M | 9.52M | 39.93M | 69.10M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 11.40M | 12.10M | 49.60M | 127.70M |
Low Estimate | 7.30M | 7.91M | 33.22M | 44.80M |
Year ago Sales | 10.38M | 6.08M | 30.99M | 39.93M |
Year over Year Growth Est. | -16.24% | 56.51% | 28.87% | 73.03% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.68 | -0.60 | -2.23 | -1.14 |
# of Estimates | 6 | 5 | 8 | 7 |
Most Recent Consensus | -0.61 | -0.48 | -2.32 | -0.75 |
High Estimate | -0.61 | -0.48 | -1.70 | -0.65 |
Low Estimate | -0.79 | -0.68 | -2.98 | -1.81 |
Year ago EPS | -0.67 | -0.61 | -2.63 | -2.23 |
Year over Year Growth Est. | -1.49% | 1.64% | 15.21% | 49.13% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 1 | 1 |
Up Last 30 Days | 3 | 2 | 5 | 6 |
Up Last 60 Days | 0 | 1 | 3 | 3 |
Down Last 7 Days | 0 | 1 | 0 | 0 |
Down Last 30 Days | 0 | 1 | 1 | 0 |
Down Last 60 Days | 3 | 2 | 5 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.68 | -0.60 | -2.23 | -1.14 |
7 Days Ago | -0.68 | -0.58 | -2.24 | -1.31 |
30 Days Ago | -0.66 | -0.59 | -2.44 | -1.97 |
60 Days Ago | -0.60 | -0.55 | -2.28 | -1.85 |
90 Days Ago | -0.60 | -0.55 | -2.27 | -1.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.67 | -0.60 | -2.08 | -1.06 |
Zacks Consensus Estimate | -0.68 | -0.60 | -2.23 | -1.14 |
Earnings ESP | 0.74% | -0.25% | 6.63% | 6.96% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.74 | -0.61 | -0.61 | -0.67 | NA |
Estimate | -0.64 | -0.67 | -0.76 | -0.77 | NA |
Difference | -0.10 | 0.06 | 0.15 | 0.10 | 0.05 |
Surprise | -15.63% | 8.96% | 19.74% | 12.99% | 6.52% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more